Changes of inflammatory markers in nasal lavage samples after 2 years of elexacaftor/tezacaftor/ivacaftor therapy in paediatric and adult cystic fibrosis patients. (PubMed, ERJ Open Res) - Sep 23, 2026 - "In the adult cohort, a trend towards increasing values was observed. Further studies are required to confirm NL as a suitable sample material for assessing airway inflammation and to substantiate the trends described in our study."
Journal • Cystic Fibrosis • Genetic Disorders • Immunology • Inflammation • Pediatrics • Pulmonary Disease • Respiratory Diseases • CXCL8 • ELANE • IL6
|
|
Anja Siedl; Dorothea Appelt; Helmut Ellemunter; Johannes Eder; Katharina Niedermayr; Teresa Fuchs; Verena Gasser
|